Clorox (CLX) Tops Q2 EPS by 9c; Boosts Outlook Modestly
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Clorox (CLX) Proves Conservative on Initial FY16 Guidance - UBS Raises PT to $110
February 5, 2016 9:49 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $110.00 (from $105.00), following the company's 2Q earnings report. CLX reported $1.14 in EPS, beating consensus estimates of $1.05. This outperformance was driven largely by +210 bps in GM expansion. CLX did not raise FY16... More
